Factors linked to symptoms in people with Wilson disease over long-term follow-up
Follows people with Wilson disease to find factors linked to their symptoms.
Key facts
- Who runs it
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 1 Jan 2004
- Expected to end
- 1 Jan 2030
- Type of study
- Observational
- Treatments tested
- low copper diet
- Record updated
- 16 July 2021
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with Wilson disease confirmed by a genetic test. It follows them over a long time to study their symptoms.
- Age
- 6 Years to 65 Years
- Sex
- All sexes can join
- Disease stage
- Wilson disease diagnosed by a genetic test
- Biomarker or test result
- Disease-causing changes in the ATP7B gene on 2 different copies of the gene
Main reasons for not taking part
- People who refuse follow-up visits cannot join
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- genetically diagnosed patients with wilson disease
Who cannot take part
- Deny follow-up
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 6 and 65 years old?
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The investigators aimed to identify factors associated with symptoms and features of Wilson disease from a large cohort during long-term follow-up
The group in the trial
- Wilson's disease cohort
Patients were clinically diagnosed according to the Leipzig Score and included in the study when they were confirmed to carry ATP7B pathogenic variants in 2 different alleles.
Treatment: low copper diet
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
- Plain-language title
- Factors linked to symptoms in people with Wilson disease over long-term follow-upGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT04965545, who can take part
- Record updated
- 16 July 2021